Advertisement
Advertisement

MIST

MIST logo

Milestone Pharmaceuticals Inc. Common Shares

1.93
USD
Sponsored
+0.04
+1.85%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

1.91

-0.02
-0.78%

MIST Earnings Reports

Positive Surprise Ratio

MIST beat 16 of 26 last estimates.

62%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.16
Implied change from Q3 25 (Revenue/ EPS)
--
/
+33.33%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-15.79%

Milestone Pharmaceuticals Inc. Common Shares earnings per share and revenue

On Nov 12, 2025, MIST reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 28.27% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.16 USD, with revenue projected to reach -- USD, implying an increase of 33.33% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Milestone Pharmaceuticals Inc. Common Shares reported EPS of -$0.12, beating estimates by 28.27%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.05%, changed from $1.91 before the earnings release to $1.93 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 7 analysts, Milestone Pharmaceuticals Inc. Common Shares is expected to report EPS of -$0.16 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement